Navigation Links
TomoTherapy files registration statement for IPO

Madison, Wis. - TomoTherapy, Inc. has filed a registration statement with the Securities and Exchange Commission for an initial public offering of common stock.

The Madison-based medical device manufacturer has filed a F......

Full article >>> apital market.

In 2006, TomoTherapy surpassed the $100 million annual revenue mark and is approaching 500 employees. The company, which was spun out of research at the University of Wisconsin-Madison, often is touted by state and biotechnology industry officials as an example of a high-tech success story, the kind that can get the attention of outside i......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 02/12/07


Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. TomoTherapy opens technical training center
3. TomoTherapy raises $223 million in IPO
4. TomoTherapy revises IPO money target
5. Hospital named for Madame Curie installs TomoTherapy system
6. TomoTherapy to sell medical devices in India
7. TomoTherapy sees sustained market advantage
8. TomoTherapys 100th radiology system reaches public sector
9. TomoTherapy extends reach to Germany
10. Cash-rich TomoTherapy has no plans for IPO
11. City of Hope adds second TomoTherapy system
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... ... Parallel 6 , the leading software as a service (SaaS) provider ... Patient Encounter CONSULT module which enables both audio and video telemedicine communication between the ... the CONSULT module, patients and physicians can schedule a face to face virtual patient ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... ... 2016 , ... Mosio, a leader in clinical research patient ... and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the hurdle ... and strategies for clinical researchers. , “The landscape of how patients receive and ...
Breaking Biology Technology:
(Date:6/7/2016)... TORONTO , June 7, 2016  Syngrafii ... begun a business relationship that includes integrating Syngrafii,s ... pilot branch project. This collaboration will result in ... for the credit union, while maintaining existing document ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
(Date:6/2/2016)... 2016   The Weather Company , an IBM Business ... industry-first capability in which consumers will be able to interact ... questions via voice or text and receive relevant information about ... Marketers have long sought an advertising solution that can ... personal, relevant and valuable; and can scale across millions of ...
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled ... medical LCD display is the latest premium product recently added to the range of ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):